CoChat

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria

Lacerda, Marcus V.G., Llanos-Cuentas, Alejandro, Krudsood, Srivicha, Lon, Chanthap, Saunders, David L., Mohammed, Rezika, Yilma, Daniel, Batista Pereira, Dhelio, Espino, Fe E.J., Mia, Reginaldo Z., Chuquiyauri, Raul, Val, Fernando, Casapía, Martín, Monteiro, Wuelton M., Brito, Marcelo A.M., Costa, Mônica R.F., Buathong, Nillawan, Noedl, Harald, Diro, Ermias, Getie, Sisay, Wubie, Kalehiwot M., Abdissa, Alemseged, Zeynudin, Ahmed, Abebe, Cherinet, Tada, Mauro S., Brand, Françoise, Beck, Hans-Peter, Angus, Brian, Duparc, Stephan, Kleim, Jörg-Peter, Kellam, Lynda M., Rousell, Victoria M., Jones, Siôn W., Hardaker, Elizabeth, Mohamed, Khadeeja, Clover, Donna D., Fletcher, Kim, Breton, John J., Ugwuegbulam, Cletus O., Green, Justin A., Koh, Gavin C.K.W. · 2019 · New England Journal of Medicine
Cited by 260

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1710775

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. Howes RE, Battle KE, Mendis KN, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg 2016;95:Suppl:15-34.27402513 · DOI · Paper page
  2. 10.1186/1475-2875-13-321 · DOI
  3. 10.1186/1475-2875-10-355 · DOI · Paper page
  4. 10.1007/s11908-007-0021-4 · DOI · Paper page
  5. 10.1016/j.actatropica.2016.04.009 · DOI
  6. Galappaththy GN, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev 2013;10:CD004389-CD004389.24163057
  7. 10.1371/journal.pmed.1002299 · DOI · Paper page
  8. 10.1186/1475-2875-9-308 · DOI
  9. 10.1371/journal.pmed.1002379 · DOI · Paper page
  10. 10.1016/S0140-6736(13)62568-4 · DOI · Paper page
  11. 10.1128/AAC.01588-16 · DOI
  12. 10.1371/journal.pmed.1001339 · DOI · Paper page
  13. 10.1073/pnas.1310402110 · doi:10.1073/pnas.1310402110
  14. Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine V: primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med 1981;97:750-759.7229509
  15. 10.4269/ajtmh.16-0779 · DOI · Paper page
  16. 10.1056/NEJMoa1802537 · DOI · Paper page
  17. 10.1093/infdis/jiv508 · DOI
  18. 10.1086/597303 · DOI · Paper page
  19. 10.1016/j.clinbiochem.2007.02.008 · DOI
  20. 10.1016/j.bcmd.2004.11.001 · DOI
  21. 10.1056/NEJMc1301936 · DOI · Paper page
  22. 10.1186/s12936-016-1145-5 · DOI
  23. 10.1038/sj.clpt.6100406 · DOI · Paper page
  24. 10.1002/bmc.1557 · doi:10.1002/bmc.1557
  25. 10.1590/0074-0276130579 · DOI
  26. 10.4269/ajtmh.2011.09-0723 · doi:10.4269/ajtmh.2011.09-0723
  27. 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
  28. 10.1371/journal.pone.0110691 · DOI
  29. 10.1186/1475-2875-12-212 · DOI · Paper page
  30. 10.1186/1475-2875-13-488 · DOI
  31. 10.1371/journal.pone.0160172 · DOI
  32. 10.1186/s12936-017-1784-1 · DOI · Paper page
  33. 10.1016/B978-0-12-397900-1.00002-5 · DOI · Paper page
  34. Kozenis (tafenoquine) approved by the Australian TGA for the radical cure of P. vivax malaria. Press release of GlaxoSmithKline September 21 2018 (http://au.gsk.com/en-au/media/press-releases/2018/kozenis-tafenoquine-approved-by-the-australian-tga-for-the-radical-cure-of-p-vivax-malaria/).

Cited by

See all 260

Metadata

Authors
Lacerda, M. V. G., Llanos-Cuentas, A., Krudsood, S., Lon, C., Saunders, D. L., Mohammed, R., Yilma, D., Batista Pereira, D., Espino, F. E. J., Mia, R. Z., Chuquiyauri, R., Val, F., Casapía, M., Monteiro, W. M., Brito, M. A. M., Costa, M. R. F., Buathong, N., Noedl, H., Diro, E., Getie, S., Wubie, K. M., Abdissa, A., Zeynudin, A., Abebe, C., Tada, M. S., Brand, F., Beck, H.-P., Angus, B., Duparc, S., Kleim, J.-P., Kellam, L. M., Rousell, V. M., Jones, S. W., Hardaker, E., Mohamed, K., Clover, D. D., Fletcher, K., Breton, J. J., Ugwuegbulam, C. O., Green, J. A., & Koh, G. C. K. W.
Venue
New England Journal of Medicine
Published
2019-01-17
Volume
380
Issue
3
Pages
215-228
ISSN
  • 0028-4793
  • 1533-4406
Cited by
260
References
0
Language
en
Funders
  • Medicines for Malaria Venture
  • GlaxoSmithKline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria. https://app.cochat.ai/papers/10.1056/nejmoa1710775
The paper
Lacerda, M. V. G., Llanos-Cuentas, A., Krudsood, S., Lon, C., Saunders, D. L., Mohammed, R., Yilma, D., Batista Pereira, D., Espino, F. E. J., Mia, R. Z., Chuquiyauri, R., Val, F., Casapía, M., Monteiro, W. M., Brito, M. A. M., Costa, M. R. F., Buathong, N., Noedl, H., Diro, E., . . . Koh, G. C. K. W. (2019). Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1710775

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.